Net Cash Provided by (Used in) Operating Activities |
-1.78M |
USD |
+72.4% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
1.56M |
USD |
-77.7% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
317K |
USD |
|
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
250M |
shares |
|
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
75.7M |
shares |
|
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-14K |
USD |
+93.1% |
Q2 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.58M |
USD |
-61.1% |
Q2 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
8.47K |
USD |
-92.5% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
43.7M |
USD |
+25.3% |
Q1 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2023 |
Q3 2024 |
Deferred Tax Assets, Gross |
45M |
USD |
+26% |
Q1 2024 |
FY 2024 |
Operating Lease, Liability |
1.27M |
USD |
|
Q2 2024 |
Q1 2025 |
Depreciation |
112K |
USD |
-56% |
Q2 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-2.57M |
USD |
+91.1% |
Q2 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
3.98M |
USD |
|
Q2 2024 |
Q1 2025 |
Operating Lease, Liability, Current |
311K |
USD |
|
Q2 2024 |
Q1 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.13 |
pure |
|
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
44.9M |
USD |
+27.1% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
99.3M |
shares |
|
Q4 2023 |
Q1 2025 |
Preferred Stock, Shares Authorized |
140M |
shares |
+13914% |
Q4 2023 |
Q1 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2023 |
Q2 2024 |
Operating Lease, Payments |
103K |
USD |
|
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q2 2024 |
Depreciation, Depletion and Amortization |
113K |
USD |
-55.6% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
1.31M |
USD |
+51.1% |
Q1 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
1.27M |
USD |
+157% |
Q4 2023 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
Q3 2024 |